TheProfitWatch

MRSN - Mersana Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
10.4 0.2 (1.92%) --- --- --- 0.0 (-0.04%) 0.28 (2.71%) --- 0.0 (-0.04%)

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.19
Diluted EPS:
-0.19
Basic P/E:
-55.7895
Diluted P/E:
-55.7895
RSI(14) 1m:
45.37
VWAP:
10.63
RVol:

Events

Period Kind Movement Occurred At

Related News